Company Filing History:
16 out of 68 
11 out of 25 
2 out of 3 Years Active: 1994-2008
Title: Innovations and Contributions of Stephen J. Garger
Introduction: Stephen J. Garger, an accomplished inventor based in Vacaville, California, holds a remarkable portfolio of 31 patents. His work primarily focuses on biotechnological innovations, particularly in the realm of vaccine development through plant systems.
Latest Patents: Among his significant contributions is the patent for the "Production of a parvovirus vaccine in plants as viral coat protein fusions." This innovation describes methods for fusing foreign peptide sequences to recombinant plant viral structural proteins, allowing for economical synthesis of fusion proteins in plants at high levels. These fusion proteins serve as effective antigens to induce the production of protective antibodies against parvovirus, specifically utilizing feline parvovirus epitopes fused to the TMV coat protein. This method demonstrates a novel approach to vaccine production, extracted, purified, characterized, and administered to animals, resulting in protective immunity.
Career Highlights: Stephen has played a vital role in advancing biotechnological research and development through his work in prominent organizations such as Large Scale Biology Corporation and Biosource Technologies, Inc. His expertise in the field has led to successful patent registrations that contribute to public health and animal welfare.
Collaborations: Garger has collaborated with esteemed colleagues, including Thomas H. Turpen and Michael J. McCulloch, who have joined him in exploring and developing innovative solutions in the life sciences sector. Their teamwork has proven instrumental in furthering the field of vaccine development.
Conclusion: Stephen J. Garger stands out as a dedicated inventor whose work is making a difference in biotechnology and vaccine development. His innovative approaches, particularly through the use of plant systems to combat parvovirus, highlight the potential of biotechnological advancements in improving health outcomes. His extensive patent portfolio exemplifies his commitment to scientific progress and innovation.